PL3750873T3 - Sposób wytwarzania n-acetylotaurynianu magnezu - Google Patents
Sposób wytwarzania n-acetylotaurynianu magnezuInfo
- Publication number
- PL3750873T3 PL3750873T3 PL20179342.9T PL20179342T PL3750873T3 PL 3750873 T3 PL3750873 T3 PL 3750873T3 PL 20179342 T PL20179342 T PL 20179342T PL 3750873 T3 PL3750873 T3 PL 3750873T3
- Authority
- PL
- Poland
- Prior art keywords
- taurinate
- acetyl
- manufacturing magnesium
- magnesium
- manufacturing
- Prior art date
Links
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 title 1
- CXJAAWRLVGAKDV-UHFFFAOYSA-M acetyltaurine(1-) Chemical compound CC(=O)NCCS([O-])(=O)=O CXJAAWRLVGAKDV-UHFFFAOYSA-M 0.000 title 1
- 229910052749 magnesium Inorganic materials 0.000 title 1
- 239000011777 magnesium Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C315/00—Preparation of sulfones; Preparation of sulfoxides
- C07C315/06—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/32—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of salts of sulfonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/02—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof
- C07C303/22—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof from sulfonic acids, by reactions not involving the formation of sulfo or halosulfonyl groups; from sulfonic halides by reactions not involving the formation of halosulfonyl groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/42—Separation; Purification; Stabilisation; Use of additives
- C07C303/44—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/02—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to acyclic carbon atoms
- C07C317/04—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
- C07F3/02—Magnesium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
- C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
- C07C309/15—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton the nitrogen atom of at least one of the amino groups being part of any of the groups, X being a hetero atom, Y being any atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BE20195372A BE1026955B1 (fr) | 2019-06-11 | 2019-06-11 | Procédé de fabrication de N-acétyl-taurinate de magnésium |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3750873T3 true PL3750873T3 (pl) | 2024-03-25 |
Family
ID=67060224
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL20179342.9T PL3750873T3 (pl) | 2019-06-11 | 2020-06-10 | Sposób wytwarzania n-acetylotaurynianu magnezu |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11053194B2 (pl) |
| EP (1) | EP3750873B1 (pl) |
| CN (1) | CN112062696B (pl) |
| BE (1) | BE1026955B1 (pl) |
| BR (1) | BR102020011608A2 (pl) |
| CA (1) | CA3082669A1 (pl) |
| DK (1) | DK3750873T3 (pl) |
| ES (1) | ES2969080T3 (pl) |
| FI (1) | FI3750873T3 (pl) |
| MX (1) | MX2020006070A (pl) |
| PL (1) | PL3750873T3 (pl) |
| PT (1) | PT3750873T (pl) |
| SI (1) | SI3750873T1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112047862A (zh) * | 2020-09-16 | 2020-12-08 | 浙江天瑞化学有限公司 | 一种乙酰牛磺酸镁的制备方法及其设备 |
| CN119504517B (zh) * | 2025-01-22 | 2025-04-18 | 浙江天启生化股份有限公司 | 一种乙酰牛磺酸镁的制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2384751A1 (fr) * | 1977-03-23 | 1978-10-20 | Francaise Coop Pharma | Nouveaux derives de la taurine a activite neuro-musculaire renforcee |
| US5582839A (en) * | 1995-04-18 | 1996-12-10 | Nutrition 21 | Magnesium taurate and other mineral taurates |
| CN1887862A (zh) * | 2006-07-19 | 2007-01-03 | 江阴南极星生物制品有限公司 | 牛磺酸镁的合成方法 |
| FR2927809B1 (fr) * | 2008-02-26 | 2011-01-14 | Tri Inov | Nouvelle utilisation de n-acetyl-taurinate de zinc. |
| EP3878445A3 (en) * | 2013-06-05 | 2021-10-27 | Synchroneuron Inc. | Acamprosate formulations, methods of using the same, and combinations comprising the same |
| CN107197511B (zh) * | 2017-07-07 | 2020-04-14 | 京信通信系统(中国)有限公司 | 一种功率调整方法和系统 |
| BE1026496B1 (fr) * | 2019-05-16 | 2020-02-19 | Synapharm Ind Synthesis | Composé et composition pour utilisation dans le traitement du syndrome prémenstruel et/ou du trouble dysphorique prémenstruel |
-
2019
- 2019-06-11 BE BE20195372A patent/BE1026955B1/fr active IP Right Grant
-
2020
- 2020-06-09 US US16/896,515 patent/US11053194B2/en active Active
- 2020-06-09 BR BR102020011608-8A patent/BR102020011608A2/pt unknown
- 2020-06-10 ES ES20179342T patent/ES2969080T3/es active Active
- 2020-06-10 SI SI202030348T patent/SI3750873T1/sl unknown
- 2020-06-10 PL PL20179342.9T patent/PL3750873T3/pl unknown
- 2020-06-10 PT PT201793429T patent/PT3750873T/pt unknown
- 2020-06-10 EP EP20179342.9A patent/EP3750873B1/fr active Active
- 2020-06-10 CA CA3082669A patent/CA3082669A1/en active Pending
- 2020-06-10 DK DK20179342.9T patent/DK3750873T3/da active
- 2020-06-10 FI FIEP20179342.9T patent/FI3750873T3/fi active
- 2020-06-11 CN CN202010530600.4A patent/CN112062696B/zh active Active
- 2020-07-13 MX MX2020006070A patent/MX2020006070A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2020006070A (es) | 2022-12-06 |
| SI3750873T1 (sl) | 2024-03-29 |
| CA3082669A1 (en) | 2020-12-11 |
| ES2969080T3 (es) | 2024-05-16 |
| BR102020011608A2 (pt) | 2020-12-15 |
| BE1026955B1 (fr) | 2020-08-04 |
| DK3750873T3 (da) | 2024-01-15 |
| US11053194B2 (en) | 2021-07-06 |
| US20200392078A1 (en) | 2020-12-17 |
| CN112062696A (zh) | 2020-12-11 |
| FI3750873T3 (fi) | 2024-01-15 |
| PT3750873T (pt) | 2024-01-08 |
| CN112062696B (zh) | 2023-07-28 |
| EP3750873B1 (fr) | 2023-12-20 |
| EP3750873A1 (fr) | 2020-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201907244D0 (en) | Method | |
| ZA202109841B (en) | Method for manufacturing mortar-based elements | |
| GB201911286D0 (en) | Method | |
| GB201913997D0 (en) | Method | |
| GB201909562D0 (en) | Method | |
| GB201917742D0 (en) | Method | |
| GB201910759D0 (en) | Method | |
| GB201907782D0 (en) | Method | |
| SI3750873T1 (sl) | Postopek izdelave magnezijevega N-acetil-tavrinata | |
| PL3733651T3 (pl) | Sposób wytwarzania kalkobutrolu | |
| GB201900940D0 (en) | Method | |
| GB201900647D0 (en) | Method | |
| GB201917060D0 (en) | Method | |
| GB201902943D0 (en) | Manufacturing method | |
| GB201917638D0 (en) | Method | |
| GB201913970D0 (en) | Method | |
| GB201910404D0 (en) | Method | |
| GB201909774D0 (en) | Method | |
| GB201909131D0 (en) | Method | |
| GB201906768D0 (en) | Method | |
| GB201901532D0 (en) | Method | |
| GB201918290D0 (en) | Method | |
| GB201917806D0 (en) | Method | |
| GB201917824D0 (en) | Method | |
| GB201917599D0 (en) | Method |